-
The signs of recovery in IPOs of biopharmaceutical companies in the US stock market indicate that companies in the later stages of research and development are more likely to go public
After more than two years of downturn, the initial public offerings (IPOs) of American biotech companies are also an important indicator of the industry's health, finally showing signs of recovery. I ...